BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$9.55
-2.00%
Mkt Cap $2.48B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
Implied Upside
+109.5%
Consensus $20.00 vs current $9.55
NASDAQ·Healthcare·Biotechnology
$9.55
-2.00%
Mkt Cap $2.48B
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
+109.5%
Consensus $20.00 vs current $9.55